Home Journals Subjects About My LA Reviewers Authors News Submit
Username: Password:
.
(close)

(Ctrl-click to select multiple journals)


How should we address you?

Your email address


Enter the three character code
Visual CAPTCHA
Privacy Statement
 
 
 
 
 
 

Alpha-Fetoprotein: From a Diagnostic Biomarker to a Key Role in Female Fertility

Authors: Christelle De Mees, Julie Bakker, Josiane Szpirer and Claude Szpirer
Publication Date: 07 Feb 2007
Biomarker Insights 2006:1 82-85

Christelle De Mees1, Julie Bakker2, Josiane Szpirer1 and Claude Szpirer1

1Université Libre de Bruxelles, Institut de Biologie et de Médecine Moléculaires, Rue Profs Jeener & Brachet, 12; B-6041 Gosselies (Charleroi), Belgium. 2University of Liège, Center for Cellular & Molecular Neurobiology, Avenue de l'Hopital 1, B36; B-4000 Liège, Belgium.

Abstract: Alpha-fetoprotein (AFP) is a well-known diagnostic biomarker used in medicine to detect fetal developmental anomalies such as neural tube defects or Down's syndrome, or to follow up the development of tumors such as hepatocellular carcinomas. However, and despite the fact that the protein was discovered almost half a century ago, little was known about its physiological function. The study of Afp knock-out mice uncovered a surprising function of AFP: it is essential for female fertility and for expression of normal female behaviors, and this action is mediated through its estrogen binding capacity. AFP sequestrates estrogens and by so doing protects the female developing brain from deleterious (defeminizing/ masculinizing) effects of these hormones.

Categories: Womens' health , Biomarkers